Weekly Digest – May 2024 Weekly Digest – May 2024 30 May 2024: Gilead’s Trodelvy Faces Setback with Bladder Cancer Trial Failure and Concerns over Early Deaths Following a major setback in NSCLC in January, Gilead announced that Trodelvy also […]
Weekly Digest – May 2024 Weekly Digest – May 2024 28 May 2024: AbbVie Highlights Strong Solid Tumor Pipeline at ASCO 2024 with New ADC Platform Data AbbVie’s ADCs are designed to target unique protein biomarkers such as c-Met (MET […]
Weekly Digest – May 2024 Weekly Digest – May 2024 28 May 2024: BioNTech Invests $25M Upfront to Enhance ADC Partnership with China’s MediLink BioNTech is paying $25 million upfront to collaborate with MediLink Therapeutics on using its TMALIN ADC […]
Weekly Digest – May 2024 Weekly Digest – May 2024 28 May 2024: AstraZeneca and Daiichi Sankyo’s ADC Falls Short in Phase III NSCLC Trial AstraZeneca and Daiichi Sankyo’s Phase III TROPION-Lung01 study revealed that datopotamab deruxtecan (Dato-DXd), did not […]
